Further analysis of the relationship between STAR expression and the clinical prognosis of SOC patients revealed that, in the overall ovarian cancer cohort, patients with high STAR expression had significantly longer overall survival (OS) compared to those with low STAR expression (Figure 4E). This evidence concerns the gene UBXN11 and ovarian carcinoma.